Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Int J Biol Macromol ; 244: 125410, 2023 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-37327923

RESUMEN

To emphasize that differences in pectin structure among cultivars play a crucial role in the texture and quality of fruits and vegetables, the sugar content and methyl-esterification of pectin fractions from 13 apple cultivars was studied. Cell wall polysaccharides were isolated as alcohol-insoluble solids (AIS) and subsequently extracted to yield water-soluble solids (WSS) and chelating-soluble solids (ChSS). All fractions contained significant amounts of galacturonic acid, while sugar compositions varied between cultivars. AIS and WSS pectins showed a degree of methyl-esterification (DM) > 50 %, while ChSS pectins had either a medium (∼50 %) or low (<30 %) DM. Homogalacturonan as major structure was studied using enzymatic fingerprinting. Methyl-ester distribution of pectin was described by degrees of blockiness and -hydrolysis. Novel descriptive parameters were obtained by measuring the levels of methyl-esterified oligomers released by endo-PG (DBPGme) and PL (DBPLme). Pectin fractions differed in relative amounts of non-, moderately-, and highly methyl-esterified segments. WSS pectins were mostly lacking non-esterified GalA sequences, while ChSS pectins had medium DM and many non-methyl-esterified blocks or a low DM with many intermediate methyl-esterified GalA blocks. These findings will be of help to better understand physicochemical properties of apple and its products.


Asunto(s)
Malus , Pectinas/química , Polisacáridos/análisis , Frutas/química , Azúcares/análisis
2.
Cell Chem Biol ; 30(9): 1104-1114.e7, 2023 09 21.
Artículo en Inglés | MEDLINE | ID: mdl-37164019

RESUMEN

Uric acid, the end product of purine degradation, causes hyperuricemia and gout, afflicting hundreds of millions of people. The debilitating effects of gout are exacerbated by dietary purine intake, and thus a potential therapeutic strategy is to enhance purine degradation in the gut microbiome. Aerobic purine degradation involves oxidative dearomatization of uric acid catalyzed by the O2-dependent uricase. The enzymes involved in purine degradation in strictly anaerobic bacteria remain unknown. Here we report the identification and characterization of these enzymes, which include four hydrolases belonging to different enzyme families, and a prenyl-flavin mononucleotide-dependent decarboxylase. Introduction of the first two hydrolases to Escherichia coli Nissle 1917 enabled its anaerobic growth on xanthine as the sole nitrogen source. Oral supplementation of these engineered probiotics ameliorated hyperuricemia in a Drosophila melanogaster model, including the formation of renal uric acid stones and a shortened lifespan, providing a route toward the development of purinolytic probiotics.


Asunto(s)
Gota , Hiperuricemia , Humanos , Animales , Ácido Úrico/metabolismo , Anaerobiosis , Drosophila melanogaster/metabolismo , Gota/metabolismo , Purinas/metabolismo , Escherichia coli/metabolismo , Hidrolasas/metabolismo
3.
Food Chem ; 371: 131073, 2022 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-34537621

RESUMEN

The effect of high pressure homogenization (HPH) compared with simple blending and milling on mixed juice properties, including water-soluble pectin (WSP) characteristics and total carotenoid bioaccessibility (TCB) was investigated. Overall, HPH treatments, which comprised of varied pressures, passes and inlet temperature (IT) affected WSP characteristics. Increased pressure showed decreased molecular weight (Mw), galacturonic acid (GalA) content and branching, and enhanced degree of methylesterification (DM) and chain linearity, suggesting degradation of RG-I fragments. Two passes at 140 MPa enhanced GalA content, nevertheless it reduced DM, implying rearrangement of depolymerized fractions. Besides, elevated IT combined with high pressure increased GalA content and DM signifying thermo-solubilization of certain HG-rich pectin. Notably, the TCB was enhanced by higher pressure and elevated temperature, which had positive relationship with DM and chain linearity of WSP and negative correlations with GalA content and Mw. Results highlighted the potential of HPH to improve WSP characteristics to enhance TCB.


Asunto(s)
Carotenoides , Pectinas , Carotenoides/análisis , Manipulación de Alimentos , Frutas/química , Agua
4.
Carbohydr Polym ; 250: 116890, 2020 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-33049879

RESUMEN

Pectin, a major polysaccharide found in the cell walls of higher plants, plays major roles in determining the physical and nutritional properties of fruit- and vegetable-based products. An in-depth understanding of the effects of processing operations on pectin structure and functionality is critical for designing better products. This review, therefore, focuses on the progress made in understanding the effects of processing on pectin structure, further on pectin functionality, consequently on product properties. The effects of processing on pectin structure are highly dependent on the processing conditions. Targeted control of pectin structure by applying various processing operations could enhance textural, rheological, nutritional properties and cloud stability of products. While it seems that optimizing product quality in terms of physical properties is counteracted by optimizing the nutritional properties. Therefore, understanding plant component biosynthesis mechanisms and processing mechanisms could be a major challenge to balance among the quality indicators of processed products.


Asunto(s)
Pared Celular/metabolismo , Manipulación de Alimentos/métodos , Frutas/metabolismo , Pectinas/química , Pectinas/metabolismo , Temperatura , Verduras/metabolismo , Reología
5.
Ann Neurol ; 67(4): 526-33, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20437588

RESUMEN

OBJECTIVE: Thrombin mediates the life-threatening cerebral edema that occurs after intracerebral hemorrhage. Therefore, we examined the mechanisms of thrombin-induced injury to the blood-brain barrier (BBB) and subsequent mechanisms of BBB repair. METHODS: Intracerebroventricular injection of thrombin (20U) was used to model intraventricular hemorrhage in adult rats. RESULTS: Thrombin reduced brain microvascular endothelial cell (BMVEC) and perivascular astrocyte immunoreactivity-indicating either cell injury or death-and functionally disrupted the BBB as measured by increased water content and extravasation of sodium fluorescein and Evans blue dyes 24 hours later. Administration of nonspecific Src family kinase inhibitor (PP2) immediately after thrombin injections blocked brain edema and BBB disruption. At 7 to 14 days after thrombin injections, newborn endothelial cells and astrocytes were observed around cerebral vessels at the time when BBB permeability and cerebral water content resolved. Delayed administration of PP2 on days 2 through 6 after thrombin injections prevented resolution of the edema and abnormal BBB permeability. INTERPRETATION: Thrombin, via its protease-activated receptors, is postulated to activate Src kinase phosphorylation of molecules that acutely injure the BBB and produce edema. Thus, acute administration of Src antagonists blocks edema. In contrast, Src blockade for 2 to 6 days after thrombin injections is postulated to prevent resolution of edema and abnormal BBB permeability in part because Src kinase proto-oncogene members stimulate proliferation of newborn BMVECs and perivascular astrocytes in the neurovascular niche that repair the damaged BBB. Thus, Src kinases not only mediate acute BBB injury but also mediate chronic BBB repair after thrombin-induced injury.


Asunto(s)
Barrera Hematoencefálica , Edema Encefálico/prevención & control , Hemostáticos/efectos adversos , Pirimidinas/uso terapéutico , Trombina/efectos adversos , Familia-src Quinasas/antagonistas & inhibidores , Animales , Antígenos de Superficie/metabolismo , Barrera Hematoencefálica/efectos de los fármacos , Barrera Hematoencefálica/lesiones , Barrera Hematoencefálica/fisiopatología , Edema Encefálico/inducido químicamente , Edema Encefálico/patología , Bromodesoxiuridina/metabolismo , Permeabilidad Capilar/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Azul de Evans , Fluoresceína , Regulación de la Expresión Génica/efectos de los fármacos , Proteína Ácida Fibrilar de la Glía/metabolismo , Inyecciones Intraventriculares/métodos , Masculino , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Agua/metabolismo
6.
Neurobiol Dis ; 37(3): 549-57, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19944161

RESUMEN

Classically, the cell cycle is regarded as the process leading to cellular proliferation. However, increasing evidence over the last decade supports the notion that neuronal cell cycle re-entry results in post-mitotic death. A mature neuron that re-enters the cell cycle can neither advance to a new G0 quiescent state nor revert to its earlier G0 state. This presents a critical dilemma to the neuron from which death may be an unavoidable but necessary outcome for adult neurons attempting to complete the cell cycle. In contrast, tumor cells that undergo aberrant cell cycle re-entry divide and can survive. Thus, cell cycle inhibition strategies are of interest in cancer treatment but may also represent an important means of protecting neurons. In this review, we put forth the concept of the "expanded cell cycle" and summarize the cell cycle proteins, signal transduction events and mitogenic molecules that can drive a neuron into the cell cycle in various CNS diseases. We also discuss the pharmacological approaches that interfere with the mitogenic pathways and prevent mature neurons from attempting cell cycle re-entry, protecting them from cell death. Lastly, future attempts at blocking the cell cycle to rescue mature neurons from injury should be designed so as to not block normal neurogenesis.


Asunto(s)
Encefalopatías/fisiopatología , Ciclo Celular/fisiología , Degeneración Nerviosa/fisiopatología , Encefalopatías/tratamiento farmacológico , Encefalopatías/metabolismo , Ciclo Celular/efectos de los fármacos , Proteínas de Ciclo Celular/efectos de los fármacos , Proteínas de Ciclo Celular/genética , Proteínas de Ciclo Celular/metabolismo , Muerte Celular/efectos de los fármacos , Muerte Celular/fisiología , Evaluación Preclínica de Medicamentos/métodos , Genes cdc/efectos de los fármacos , Genes cdc/fisiología , Humanos , Degeneración Nerviosa/tratamiento farmacológico , Degeneración Nerviosa/metabolismo , Neurogénesis/efectos de los fármacos , Neurogénesis/fisiología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología
7.
J Ethnopharmacol ; 112(2): 327-32, 2007 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-17451897

RESUMEN

In the present studies, the effect of paeoniflorin (PF), one of the main compounds extracted from Paeoniae radix, in alleviating the neurological impairment following unilateral striatal 6-hydroxydopamine (6-OHDA) lesion was examined in Sprague-Dawley rats. Sub-chronic PF (2.5, 5 and 10 mg/kg, s.c., twice daily for 11 days) administration dose-dependently reduced apomorphine (APO)-induced rotation, suggesting that PF had an ameliorative effect on the 6-OHDA-induced neurological impairment. Notably, PF had no direct action on dopamine D(1) receptor or dopamine D(2) receptor indicated by the competitive binding experiments. These results suggest that PF, an active component of Paeoniae radix, might provide an opportunity to introduce a non-dopaminergic management of Parkinson's disease.


Asunto(s)
Conducta Animal/efectos de los fármacos , Benzoatos/farmacología , Hidrocarburos Aromáticos con Puentes/farmacología , Glucósidos/farmacología , Enfermedad de Parkinson Secundaria/tratamiento farmacológico , Enfermedad de Parkinson Secundaria/psicología , Animales , Apomorfina/farmacología , Benzazepinas/metabolismo , Benzoatos/administración & dosificación , Benzoatos/química , Unión Competitiva/efectos de los fármacos , Hidrocarburos Aromáticos con Puentes/administración & dosificación , Hidrocarburos Aromáticos con Puentes/química , Agonistas de Dopamina/farmacología , Antagonistas de Dopamina/metabolismo , Glucósidos/administración & dosificación , Glucósidos/química , Hidroxidopaminas , Técnicas In Vitro , Masculino , Membranas/efectos de los fármacos , Membranas/metabolismo , Microinyecciones , Monoterpenos , Neostriado/efectos de los fármacos , Neostriado/metabolismo , Enfermedad de Parkinson Secundaria/inducido químicamente , Racloprida/metabolismo , Ratas , Ratas Sprague-Dawley , Conducta Estereotipada/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA